Multidrug resistance in amoebiasis patients

Indian Journal of Medical Research

Volumn 124, Issue 2, 2006, Pages 189-194

  Bansal, Devendra ^a   Sehgal, Rakesh ^a   Chawla, Yogesh ^a   Malla, Nancy ^a   Mahajan, R C ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

E. dispar; EhPgp1; Entamoeba histolytica; Multidrug resistance; Multiplex RT PCR

Indexed keywords

ANTIAMEBIC AGENT; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PROTOZOAL DNA; PROTOZOAL RNA;

AMEBIASIS; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DNA EXTRACTION; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; ISOLATION PROCEDURE; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANIMALS; DRUG RESISTANCE, MULTIPLE; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; GENES, MDR; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33749474364     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Amoebiasis. Weekly Epidemiol Rec 1997; 72: 97-9.
2. Martinez-Palomo A, Martinez-Baez M. Selective primary health care: strategies of disease in the developing world. X. Amebiasis. Rev Infect Dis 1983; 5: 1093-102.
3. Pillai DR, Keystone JS, Sheppard DC, MacLean JD, MacPherson DW, Kain KC. Entamoeba histolytica and Entamoeba dispar: epidemiology, and comparison of diagnostic methods in a setting of non endemicity. Clin Infect Dis 1999; 29: 1315-8.
4. Burchard. CD, Mirelman D. Entamoeba histolytica virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes. Exp Parasitol 1988; 66: 231-42.
5. Bansal D, Sehgal R, Chawla R, Mahajan RC, Malla N. In vitro activity of antiamoebic drugs against clinical isolates of Entamoeba histolytica and Entamoeba dispar. Ann Clin Microb Antimicrob 2004; 3: 27.
6. Hanna RM, Dahniya MH, Badr SS, El-Betagy A. Percutaneous catheter drainage in drug-resistant amoebic liver abscess. Trop Med Int Health 2000; 5: 578-81.
7. Orozco E, Hernandez F, Rodriguez M. Isolation and characterization of Entamoeba histolytica mutant resistant to emetine. Mol Biochem Parasitol 1985; 15: 49-59.
8. Samarawickrema NA, Brown DM, Upcroft JA, Thammapalerd N, Upcroft P. Involvement of superoxide dismutase and pyruvate: ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. J Antimicrob Chemother 1997; 40: 833-40.
9. Prabhu R, Sehgal R, Chakraborti A, Malla N, Ganguly N, Mahajan RC. Isolation of emetine resistant clones of Entamoeba histolytica by petri dish agar method. Indian J Med Res 2000; 111: 11-3.
10. Amyes SG, Gemmell CG. Antibiotic resistance in bacteria. J Med Microbiol 1992; 36: 4-29.
11. Pasten I, Gotteaman MM. Multiple drug resistant in human cancer. New Engl J Med 1987; 316: 1388-93.
12. Fojo A, Akiyama SI, Gottesman MM, Pasten I. Reduced accumulation in multiple drug resistant human KB carcinoma cell lines. Cancer Res 1985; 45: 3002-7.
13. Descoteaux S, Ayala P, Samuelson J, Orozco E. Increase in mRNA of multiple Eh pgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. Gene 1995; 164: 179-84.
14. Ayala P, Samuelson J, Wirth D, Orozco E. Entamoeba histolytica: Physiology of multidrug resistance. Exp Parasitol 1990; 71: 169-75.
15. Orozco E, Lopez C, Gomez C, Perez DG, Marchat L, Banuelos C, et al. Multidrug resistance in the protozoan parasite Entamoeba histolytica. Parasite Int 2002; 51: 353-9.
16. Gomez C, Perez D, Lopez-Bayghen E, Orozco E. Transcriptional analysis of the EhPgp1 promoter of Entamoeba histolytica multidrug-resistant mutant. J Biol Chem 1998; 273: 7277-84.
17. Perez DG, Gomez C, Lopez-Bayghen E, Tannich E, Orozco E. Transcriptional analysis of the EhPgp5 promoter of Entamoeba histolytica multidrug-resistant mutant. J Biol Chem 1998; 273: 7285-92.
18. Orozco E, Gomez C, Perez DG. Multidrug resistance in Entamoeba histolytica. Parasitol Today 1995; 11: 473-5.
19. Gros P, Croop I, Roninson I, Varshasky A, Housman DE. Isolation and characterization of DNA sequence amplified in multidrug resistant hamster cells. Proc Natl Acad Sci USA 1986; 83: 337-41.
20. Chen CJ, Chin JE, Ueda K, Clark DP, Pasten I, Gottesman MM, et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug resistant human cells. Cell 1986; 47: 381-9.
21. Ullman B. Multidrug resistance and P-glycoproteins in parasitic protozoa. J Bioenerg Biomemb 1995; 27: 77-84.
22. Cowman AF, Karcz SR. The pfmdr gene homologues of Plasmodium falciparum. Acta Leiden 1991; 60: 121-9.
23. Johnson PJ, Schuck BL, Delgadillo MG. Analysis of a single-domain P-glycoprotein gene in the early-diverging protist Trichomonas vaginalis. Mol Biochem Parasitol 1994; 66: 127-37.
24. Upcroft JA, Upcroft P. Drug resistance in Giardia. Parasitol Today 1993; 9: 187-90.
25. Ouellette M, Papadopoulou B. Mechansims of drug resistance in Leishmania. Parasitol Today 1993; 9: 150-3.
26. Mathur TV, Kaur J. The frequency of excretion of cysts of Entamoeba histolytica in known cases of non-pathogenic amoebic colitis based on 21 stool examination. Indian J Med Res 1973; 61: 330-3.
27. United States Public Health Service Publication (USPHS), Center Dis Cont Bull 1948.
28. Robinson GL. The laboratory diagnosis of human parasite amoebae. Trans R Soc Trop Med Hyg 1968; 62: 285-94.
29. Bansal D, Sehgal R, Chawla Y, Mahajan RC, Malla N. Comparative evaluation of hexokinase isoenzyme typing and antigen detection for differentiation of Entamoeba histolytica and Entamoeba dispar. Nepal Med Coll J 2004; 6: 123-5.
30. Diamond LS, Harlow DR, Cunnick CC. A new medium for the axenic cultivation of the E. histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 1978; 73: 431-2.
31. Sambrook J, Russell DW. Molecular cloning: a laboratory manual. Cold spring Harbour, New York: Cold spring Harbour Press; 2001.
32. Bansal D, Sehgal R, Chawla Y, Malla N, Mahajan RC. Cytokine mRNA expressions in symptomatic vs asymptomatic patients. Parasite Immunol 2005; 27: 37-43.
33. Descoteaux S, Ayala P, Orozco E, Samuelson J. Primary sequence of two P-glycoprotein genes of Entamoeba histolytica. Arch Med Res 1992; 23: 23-5.
34. Anand PK, Kaul D. Vitamin D3-dependent pathway regulates TACO gene transcription. Biochem Biophys Res Commun 2003; 310: 876-7.
35. Samueloson J, Ayala P, Orozco E, Wirth D. Emetine resistant mutants of E. histolytica over expresses mRNA for multidrug resistance. Arch Invest Med 1990; 21: 1893-7.
36. Biedler JL. Genetic aspects of multidrug resistance. Cancer 1992; 70 (Suppl): 1799-809.
37. Singh N, Singh RT, Sunder S. Novel mechanism of drug resistance in kala azar field isolates. J Infect Dis 2003; 188: 600-7.